Voyageur Pharmaceuticals Ltd. (TSXV:VM)
Canada · Delayed Price · Currency is CAD 0.1350
+0.0150 (12.50%)
Nov 9, 2026, 4:00 PM EST
Voyageur Pharmaceuticals Revenue
Voyageur Pharmaceuticals had revenue of 14.66K CAD in the quarter ending August 31, 2026, with 32.74% growth. This brings the company's total for the last twelve months to 50.85K, up 360.63% year-over-year. In the fiscal year ending November 30, 2025, Voyageur Pharmaceuticals had annual revenue of 11.69K. That makes Voyageur Pharmaceuticals the 46,788th largest company in the world by revenue and 1,093rd in Canada.
Revenue (ttm)
50.85K
Revenue Growth
+360.63%
P/S Ratio
604.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
30.72M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | 11.69K | - | - |
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | - | - | - |
| Nov 30, 2022 | - | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| iAnthus Capital Holdings | 197.59M |
| Planet 13 Holdings | 131.28M |
| 1CM Inc. | 75.45M |
| Rubicon Organics | 64.23M |
| LSL Pharma Group | 41.83M |
| MediPharm Labs | 41.46M |
| Medicure | 32.08M |
| ZYUS Life Sciences | 374.00K |
Voyageur Pharmaceuticals News
- 5 weeks ago - Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement - Newsfile Corp
- 6 weeks ago - Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt - Newsfile Corp
- 3 months ago - Voyageur Pharmaceuticals Advances Mueller Iodine Extraction Process with 99.8% Purity Results and Planned Field Pilot Testing - TheNewswire
- 3 months ago - Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker - Newsfile Corp
- 4 months ago - Voyageur Pharmaceuticals Engages Fluor to Advance Feasibility Studies for Iodine Production and Integrated Contrast Drug Manufacturing Facility - TheNewswire
- 4 months ago - Voyageur Pharmaceuticals Evaluating Three Locations in the United States for Integrated Iodine and Barium Contrast Media Manufacturing Facility, a Multi-Phase Investment Expected to Generate Significant Economic Impact and High-Skilled Jobs; Competitive Site Selection Process Underway - TheNewswire
- 5 months ago - Voyageur Pharmaceuticals Ltd. Submits Multi-Year Area-Based Exploration Permit Application for Bulk Sampling and Feasibility Support at Frances Creek Barite Project - TheNewswire
- 5 months ago - Voyageur Announces Closing Of Non-Brokered Private Placement Pursuant To Listed Issuer Financing Exemption - TheNewswire